Nautilus Biotechnology to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference Life Science Investing
Medtronic reports full year and fourth quarter fiscal 2024 financial results; announces dividend increase Life Science Investing
Sona Nanotech Touts "Superior" Results from Animal Study for Cancer Therapy, Eyes In-human Study Nanotech Investing
Aligos Therapeutics Announces Six Abstracts Accepted for Presentation at EASL 2024 Life Science Investing
MiNK Presents AgenT-797 Clinical Activity in Immune-Compromised Transplant Patient with Severe ARDS at ATS Annual Meeting Life Science Investing
Atea Pharmaceuticals Presents New Data Showcasing Potential Best-in-Class Combination Profile of Bemnifosbuvir and Ruzasvir for Treatment of Hepatitis C Virus at EASL Congress 2024 Life Science Investing
Dyne Therapeutics Announces Pricing of $325.5 Million Public Offering of Common Stock Life Science Investing
Kronos Bio Appoints Deborah Knobelman, Ph.D. as Chief Operating Officer and Chief Financial Officer Life Science Investing
Aligos Therapeutics Announces the Completion of Enrollment in the ALG-055009 Phase 2a HERALD Study for the Treatment of MASH Life Science Investing
